www.bioscience.co.uk
Sales & Support: +44 (0)1223 316 855

Cambridge Bioscience partners with Cube Biotech

Cambridge Bioscience is delighted to announce a new strategic distribution partnership with Cube Biotech, following our recent acquisition of Stratech Scientific. This extends the availability of Cube Biotech’s innovative membrane protein technologies, protein purification solutions and specialist research services to scientists across the UK and Ireland. 

The partnership will provide researchers with streamlined access to Cube Biotech’s comprehensive portfolio of products and services, including membrane protein stabilisation technologies, protein purification reagents, nanodisc and copolymer platforms, active membrane protein targets, proteomics tools and custom protein services. These solutions are designed to support applications in structural biology, drug discovery, protein engineering, membrane protein research and biotherapeutic development. 

Cube Biotech is a Germany-based life science company specialising in membrane protein technologies and protein research solutions. Building on decades of expertise in membrane protein expression, purification and crystallisation, the company develops innovative products and services that help researchers overcome the challenges associated with membrane protein isolation, stabilisation and characterisation. Its portfolio includes proprietary NativeMP™ technologies, copolymer nanodisc platforms, protein purification products and custom scientific services that enable high-quality, reproducible research. 

Through this partnership, Cambridge Bioscience will provide local technical support, product expertise and customer service, ensuring researchers across the UK and Ireland can fully leverage Cube Biotech’s trusted technologies and specialist capabilities to accelerate their research and scientific discoveries. 

This collaboration further strengthens Cambridge Bioscience’s commitment to supporting the UK and Ireland life science community with high-quality tools and technologies that accelerate research, innovation and discovery.

Learn more about Cube Biotech’s portfolio or contact our Cube Biotech specialists.

Published 30 Jun 2026